Page last updated: 2024-09-05

tak 779 and Colorectal Neoplasms

tak 779 has been researched along with Colorectal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cambien, B; Ferrua, B; Karimdjee, BF; Martini, V; Pitard, B; Richard-Fiardo, P; Schmid-Alliana, A; Schmid-Antomarchi, H	1

Other Studies

1 other study(ies) available for tak 779 and Colorectal Neoplasms

Article	Year
CCL5 neutralization restricts cancer growth and potentiates the targeting of PDGFRβ in colorectal carcinoma. PloS one, 2011, Volume: 6, Issue:12 Topics: Amides; Animals; Antibodies, Neutralizing; Cell Movement; Cell Proliferation; Chemokine CCL5; CHO Cells; Colorectal Neoplasms; Cricetinae; Cricetulus; Disease Progression; Female; HT29 Cells; Humans; Leukocytes; Mice; Molecular Targeted Therapy; Neoplasm Metastasis; Quaternary Ammonium Compounds; Receptor, Platelet-Derived Growth Factor beta; Receptors, CCR5; Treatment Outcome	2011

Article

Year

CCL5 neutralization restricts cancer growth and potentiates the targeting of PDGFRβ in colorectal carcinoma.

PloS one, 2011, Volume: 6, Issue:12

Topics: Amides; Animals; Antibodies, Neutralizing; Cell Movement; Cell Proliferation; Chemokine CCL5; CHO Cells; Colorectal Neoplasms; Cricetinae; Cricetulus; Disease Progression; Female; HT29 Cells; Humans; Leukocytes; Mice; Molecular Targeted Therapy; Neoplasm Metastasis; Quaternary Ammonium Compounds; Receptor, Platelet-Derived Growth Factor beta; Receptors, CCR5; Treatment Outcome

2011